Highlighting Features:
• Pristine+ elutes Everolimus drug which is the most preferred drug by most of the interventional cardiologists
• The basic stent platform for Pristine+ is L605 Cobalt Chromium stent
• The strut thickness for Pristine+ is 60 μm
• Pristine+ displays minimum recoil and excellent radial strength contributed by its unique open and closed cell stent design and strut locking mechanism
• Pristine+ comes with rapid exchange Delivery System which enhances its efficacy
• Uniform Everolimus Coating thickness and precise in Everolimus Drug Release Kinetics as 95 +/- 5% of Everolimus is released within 120 days
• Hydrophilic Coated Stent Delivery System
• Designed for utmost safety – Pristine+ displays one of the lowest entry profiles
• Completely biodegradable, biocompatible polymer (PLGA carrier) – Loading dose density of 1.0μg/mm²